Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
B.1.301EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.308EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.210EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.325EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.590EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.116EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.496EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.438.4EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
AY.49 (Delta)EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
FZ.2EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
FY.4EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.497EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
EN.1.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
AY.30 (Delta)EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
AY.85 (Delta)EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XBB.6.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BF.21EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
FK.1.3.2EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XBFEWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.5.6EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BF.11.5EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XBF.7.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
FY.5.3EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
FP.2.1.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XBB.2.9EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
FL.2.2EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
JW.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
JL.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.571EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
AY.55 (Delta)EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XAMEWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.239EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.574EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.355EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
GA.7.2EWon-ECACACAATCGATGCGCAGTA20502636526346R-463.749South Korea
B.1.403EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
A.27EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BQ.1.1.30EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BQ.1.9EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
GW.2EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XBB.1.40EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
FY.7EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BQ.1.2.2EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.367EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
GK.1.9EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BN.1.3.13EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.385EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XBB.1.5.45EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.244EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
JD.2.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used